Dyck

: 1993 Der Nervenarzt Nacom Retard; Entry into the gentler Levodopa Therapy for Parkinson's Disease. The first Levodopa with Long Term Effectiveness., Carbidopa-Levodopa, Du Pont Pharma, Painting image of a desert. The image is split in half one side is day light the other is night time. Above each side reads "For the Day" and "For the Night".

: 1993 Der Nervenarzt Neogama Forte; New. Your individual Sulpirid Therapy! Neogamaforte. Sulpirid 200 mg. Below the list price., Sulpirid, Hormosan-Kwizda, image of a tablet broken into three pieces with a chart showing dosage according to corresponding disorder.

: 1993 Der Nervenarzt Neuro-Vibolex; If nerves are particularly burdened.. Neuro modulation. Central and Peripheral. Pain Relief., Thioctic Acid, Chephasaar, Image of a rope being pulled by a white person's hand but the rope is starting to break. An image of a brain and a neuron are featured beside the words "Central + peripheral".

: 1993 Der Nervenarzt Neuroplant Forte; From minor to major with Neuroplantforte. Documented effect. High doses. SJW preparation. High compliance. Dose: 2x1 daily capsel. Highly compatible .The herbal antidepressant of the new generation., Norgesic Forte, Spitzner, Image of a statue of Mozart.

: 1993 Der Nervenarzt Neurothioct; Misperceptions in diabetic polyneuropathy. New. Neurothioct. Just right. Friendly sized tablettes. Quick drug release. Accessible dosages. Another advance from Nordmark's Neuropathy Therapy Program., Neurothioct, Nordmark Arzeimittel GmbH, Image of three metal tone makers.

: 1993 Der Nervenarzt Neurotrat Forte; A therapeutic concept prevails. Highlights. 20 years of NeurotratForte., Neurotrat Forte, Nordmark, 3 stars rising from the bottom left. The uppermost star is wrapped in a banner that says "highlights".

: 1993 Der Nervenarzt Nimotop; Nimotop protects the brain and independence. Brain function disorders in old age are the expression of neuronal damage. Nimotop acts directly on neurons and protects it from calcium overload. Used early on, Nimotop stops the progression and improves symptoms., Nimodipine, Tropon Bayer, Image of an elderly woman and middle age man. The elderly woman is holding a basket and smiling at the middle aged man. They are outside.

: 1993 Der Nervenarzt Nimotop; Nimotop protects the brain and its performance. Brain disorders in the eldery are the expression of neuronal damage. Nimotop acts directly on neurons and protects it from calcium overload. Nimotop improves not only the symptoms, but can delay furhter progression of the disease., Nimodipine, Tropon Bayer, Image of an old man standing with a woman and they are reading an architectural drawing. He has a smile on his facce and is pointing out something to the middle aged woman. Both individuals are white.

: 1993 Der Nervenarzt Nipolept; The Trend. More and more patients are being treated with Nipolept. Proven in clinic and every day life. Well tolerated; particularly low rate of extrapyramidal motor disorders. Convincing antipsychotic activity., Zotepin, Klinge Pharma under licensing of Fujisawa Pharmaceutical, Image of stick people, many of them are grouped together but as the image moves from right to left the stick people become more sparse.

: 1993 Der Nervenarzt Nipolept; The Trend. Nipolept. Antipsychotic., Zotepin, Klinge Pharma under licensing of Fujisawa Pharmaceutical, Image of 4 pill boxes with the varying strength.

: 1993 Der Nervenarzt PK-Merz; Crohn's Parkinson's. NMDA Antagonism. New scientific studies prove that PK-Merz acts as a NMDA antagonist. Through NMDA receptor blockades PK-Merz is normalized, pathologically altering the balance between excitation and inhibition. PK-Merz protects dopaminergic neurons of S. nigra from further damaging calcium influx and can thus slow the progression of the disease. Therefore, PK-Mertz is a good basic therapy for your Parkinson's Patients., Amantadine Sulfate, Merz Pharma, Diagram of the NDMA Receptor and how the use of PK-Merz changes it. Moreover, there is an image of an arrow pointing upwards with a messy drawn arrow beside it.

: 1993 Der Nervenarzt PK-Merz; Crohn's Parkinson's. NMDA Antagonism. New scientific studies prove that PK-Merz acts as a NMDA antagonist. Through NMDA receptor blockades PK-Merz is normalized, pathologically altering the balance between excitation and inhibition. PK-Merz protects dopaminergic neurons of S. nigra from further damaging calcium influx and can thus slow the progression of the disease. Therefore, PK-Mertz is a good basic therapy for your Parkinson's Patients., Amantadine Sulfate, Merz-Pharma, Diagram of the NDMA Receptor and how the use of PK-Merz changes it. Moreover, there is an image of an arrow pointing upwards with a messy drawn arrow beside it.

Main menu